ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2025
Sex-specific glomerular filtration rate changes in response to acute hemoglobin exposure.
Article in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sex determines cardiac and renal Vulnerability to chronic hemoglobin toxicity.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Hemoglobin (Hb) toxicity is a known contributor to acute kidney injury (AKI), particularly under hemolytic conditions where cell-free Hb is present in circulation. When the endogenous Hb scavenger protein haptoglobin becomes saturated with cognate ligand Hb, excess unbound cell-free Hb extravasates into tissues, including the kidneys, leading to oxidative stress, inflammation, and impaired renal function. Although sex-based differences in AKI susceptibility have been observed, the protective role of hormones in modulating the severity of Hb-induced kidney injury remains unclear. In this study, we evaluated the impact of biological sex, specifically estrous cycle status, on renal responses to acute Hb exposure. Glomerular filtration rate (GFR) was measured noninvasively using the Medibeacon transdermal device that detects clearance of a fluorescent tracer (FITC-Sinistrin). Across all groups, the GFR declined at 2 h post-exposure to Hb; however, only females in estrous fully recovered by 24 h. Males and non-estrous females showed sustained reductions in GFR, suggesting impaired renal recovery. Injury biomarkers for kidney, liver, urine, and heart, including KIM-1, bilirubin, creatinine, troponin, and others, showed significant improvement in females during estrous compared to males and non-estrous females. All groups exhibited some degree of toxicity from the Hb, as demonstrated by elevated levels of markers compared to the control group. Nonetheless, these findings suggest that the hormonal levels related to the estrous cycle protect against cell-free Hb-induced acute renal and cardiac injury, potentially through modulation of inflammatory signaling pathways. Understanding sex- and hormone-dependent responses to Hb toxicity is critical for developing targeted therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.